A CLINICIAN'S GUIDE TO CANNABINOID SCIENCE

A CLINICIAN'S GUIDE TO CANNABINOID SCIENCE

Editorial:
CAMBRIDGE UNIVERSITY PRESS
Año de edición:
Materia
Neurología
ISBN:
978-1-108-73075-4
Páginas:
256
N. de edición:
1
Idioma:
Inglés
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

28,00 €

Despues:

26,60 €

• Part I. An Introduction to Cannabinoid Science:
1. An introduction to the botany and history of cannabis
2. 9 -tetrahydrocannabinol (THC) and cannabidiol (CBD)
3. The endocannabinoids
4. Approved cannabinoid therapies for clinical use
5. The safety of cannabis and cannabinoids in clinical practice
• Part II. Potential Therapeutic Uses of Cannabinoids in Clinical Practice:
6. Cannabinoids and pain
7. Cannabinoids and neuropsychiatry
8. Cannabinoids in sleep and circadian rhythms
9. Cannabinoids and inflammation and autoimmune disorders
10. Cannabinoids and the eye
11. Cannabinoids and the skin.

Medical marijuana and the promise of medical advances with cannabinoids is a controversial topic. This book provides clinicians with credible, peer-reviewed science to advise patients on the use of cannabinoids in practice. From the history of cannabis to the recent discoveries, chapters include the science of cannabinoids, changes in the legal and regulatory landscape, and the emerging area of endocannabinoids. The book differentiates approved cannabinoids from cannabis and medical marijuana and stimulates clinicians to think about the risks and benefits of these two drugs. It provides the factual background for clinicians to lead the discussion on the continued use of marijuana, ongoing areas of research and future advances and development of new medications for treatment. An invaluable guide for all specialists in the pharmaceutical sciences, toxicologists, biochemists, neurologists, psychiatrists, addiction specialists, as well as primary care physicians, nurse practitioners, and regulators and policymakers.

Features
• Provides historical context on the use of cannabis and the scientific discoveries related to cannabinoids, providing an insight into the ever-developing science of cannabinoids
• The evaluation of peer-reviewed medical literature on cannabinoids increases clinician confidence in the scientific findings presented
• Highlights the differences between approved cannabinoids and medical marijuana, improving understanding of the flood of information now available

Author
Steven James, University of California, San Diego
Steven James, MD is a psychiatrist and author living in southern California with over three decades in pharmaceutical research.